Category: Proteins & Peptides

Active filters

Reference: GTX85247-PEP

SKA2 peptide is used for blocking the activity of SKA2 antibody (catalog number GTX85247). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.

Reference: GFH21AF-100

Fms-related tyrosine kinase 3 ligand (FLT-3 Ligand) is a growth factor that regulates hematopoietic cell proliferation. FLT-3 Ligand signalling is transmitted through the fms-related tyrosine kinase 3 (FLT-3) receptor. FLT-3 Ligand promotes the long-term expansion and differentiation of pro-B cells in the presence of Interleukin-7 (IL-7) or in combination of IL-7 and Interleukin-3 (IL-3). Human FLT-3 Ligand is active on mouse cells.

Reference: GTX85248-PEP

TBKBP1 peptide is used for blocking the activity of TBKBP1 antibody (catalog number GTX85248). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.

Reference: GFH21AF-1000

Fms-related tyrosine kinase 3 ligand (FLT-3 Ligand) is a growth factor that regulates hematopoietic cell proliferation. FLT-3 Ligand signalling is transmitted through the fms-related tyrosine kinase 3 (FLT-3) receptor. FLT-3 Ligand promotes the long-term expansion and differentiation of pro-B cells in the presence of Interleukin-7 (IL-7) or in combination of IL-7 and Interleukin-3 (IL-3). Human FLT-3 Ligand is active on mouse cells.

Reference: GTX85249-PEP

Prosapip1 peptide is used for blocking the activity of Prosapip1 antibody (catalog number GTX85249). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.

Reference: GFM6-2

Fms-related tyrosine kinase 3 ligand (FLT-3 Ligand) is a growth factor that regulates hematopoietic cell proliferation. FLT-3 Ligand signalling is transmitted through the fms-related tyrosine kinase 3 (FLT-3) receptor. FLT-3 Ligand promotes the long-term expansion and differentiation of pro-B cells in the presence of Interleukin-7 (IL-7) or in combination of IL-7 and Interleukin-3 (IL-3).

Reference: GTX85250-PEP

JMJD7 peptide is used for blocking the activity of JMJD7 antibody (catalog number GTX8525). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.

Reference: GFM6-10

Fms-related tyrosine kinase 3 ligand (FLT-3 Ligand) is a growth factor that regulates hematopoietic cell proliferation. FLT-3 Ligand signalling is transmitted through the fms-related tyrosine kinase 3 (FLT-3) receptor. FLT-3 Ligand promotes the long-term expansion and differentiation of pro-B cells in the presence of Interleukin-7 (IL-7) or in combination of IL-7 and Interleukin-3 (IL-3).

Reference: GTX85251-PEP

JMJD5 peptide is used for blocking the activity of JMJD5 antibody (catalog number GTX85251). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.

Reference: GFM6-100

Fms-related tyrosine kinase 3 ligand (FLT-3 Ligand) is a growth factor that regulates hematopoietic cell proliferation. FLT-3 Ligand signalling is transmitted through the fms-related tyrosine kinase 3 (FLT-3) receptor. FLT-3 Ligand promotes the long-term expansion and differentiation of pro-B cells in the presence of Interleukin-7 (IL-7) or in combination of IL-7 and Interleukin-3 (IL-3).

Reference: GTX85252-PEP

JMJD4 peptide is used for blocking the activity of JMJD4 antibody (catalog number GTX85252). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.

Reference: GFM6-1000

Fms-related tyrosine kinase 3 ligand (FLT-3 Ligand) is a growth factor that regulates hematopoietic cell proliferation. FLT-3 Ligand signalling is transmitted through the fms-related tyrosine kinase 3 (FLT-3) receptor. FLT-3 Ligand promotes the long-term expansion and differentiation of pro-B cells in the presence of Interleukin-7 (IL-7) or in combination of IL-7 and Interleukin-3 (IL-3).